226 related articles for article (PubMed ID: 24256707)
1. Nebivolol induces, via β3 adrenergic receptor, lipolysis, uncoupling protein 1, and reduction of lipid droplet size in human adipocytes.
Bordicchia M; Pocognoli A; D'Anzeo M; Siquini W; Minardi D; Muzzonigro G; Dessì-Fulgheri P; Sarzani R
J Hypertens; 2014 Feb; 32(2):389-96. PubMed ID: 24256707
[TBL] [Abstract][Full Text] [Related]
2. Nebivolol stimulates mitochondrial biogenesis in 3T3-L1 adipocytes.
Huang C; Chen D; Xie Q; Yang Y; Shen W
Biochem Biophys Res Commun; 2013 Aug; 438(1):211-7. PubMed ID: 23886954
[TBL] [Abstract][Full Text] [Related]
3. Action and disposition of the β3-agonist nebivolol in the presence of inflammation; an alternative to conventional β1-blockers.
Sanaee F; Jamali F
Curr Pharm Des; 2014; 20(9):1311-7. PubMed ID: 23978104
[TBL] [Abstract][Full Text] [Related]
4. CNS β
Richard JE; López-Ferreras L; Chanclón B; Eerola K; Micallef P; Skibicka KP; Wernstedt Asterholm I
Am J Physiol Endocrinol Metab; 2017 Sep; 313(3):E344-E358. PubMed ID: 28588096
[TBL] [Abstract][Full Text] [Related]
5. Divergent effects of an alpha2-adrenergic antagonist on lipolysis and thermogenesis: interactions with a beta3-adrenergic agonist in rats.
Gómez-Ambrosi J; Frühbeck G; Aguado M; Milagro FI; Margareto J; Martínez AJ
Int J Mol Med; 2001 Jul; 8(1):103-9. PubMed ID: 11408957
[TBL] [Abstract][Full Text] [Related]
6. β₃-Adrenergic activation of sequential Ca(2+) release from mitochondria and the endoplasmic reticulum and the subsequent Ca(2+) entry in rodent brown adipocytes.
Hayato R; Higure Y; Kuba M; Nagai H; Yamashita H; Kuba K
Cell Calcium; 2011 Jun; 49(6):400-14. PubMed ID: 21514957
[TBL] [Abstract][Full Text] [Related]
7. Lack of evidence that nebivolol is a β₃-adrenoceptor agonist.
Frazier EP; Michel-Reher MB; van Loenen P; Sand C; Schneider T; Peters SL; Michel MC
Eur J Pharmacol; 2011 Mar; 654(1):86-91. PubMed ID: 21172342
[TBL] [Abstract][Full Text] [Related]
8. Nebivolol, a vasodilating selective beta(1)-blocker, is a beta(3)-adrenoceptor agonist in the nonfailing transplanted human heart.
Rozec B; Erfanian M; Laurent K; Trochu JN; Gauthier C
J Am Coll Cardiol; 2009 Apr; 53(17):1532-8. PubMed ID: 19389564
[TBL] [Abstract][Full Text] [Related]
9. Body fat mass reduction and up-regulation of uncoupling protein by novel lipolysis-promoting plant extract.
Mori S; Satou M; Kanazawa S; Yoshizuka N; Hase T; Tokimitsu I; Takema Y; Nishizawa Y; Yada T
Int J Biol Sci; 2009; 5(4):311-8. PubMed ID: 19421341
[TBL] [Abstract][Full Text] [Related]
10. Nebivolol protects against myocardial infarction injury via stimulation of beta 3-adrenergic receptors and nitric oxide signaling.
Zhang Z; Ding L; Jin Z; Gao G; Li H; Zhang L; Zhang L; Lu X; Hu L; Lu B; Yu X; Hu T
PLoS One; 2014; 9(5):e98179. PubMed ID: 24849208
[TBL] [Abstract][Full Text] [Related]
11. Endothelial beta3-adrenoreceptors mediate nitric oxide-dependent vasorelaxation of coronary microvessels in response to the third-generation beta-blocker nebivolol.
Dessy C; Saliez J; Ghisdal P; Daneau G; Lobysheva II; Frérart F; Belge C; Jnaoui K; Noirhomme P; Feron O; Balligand JL
Circulation; 2005 Aug; 112(8):1198-205. PubMed ID: 16116070
[TBL] [Abstract][Full Text] [Related]
12. Nebivolol induces nitric oxide release in the heart through inducible nitric oxide synthase activation.
Maffei A; Di Pardo A; Carangi R; Carullo P; Poulet R; Gentile MT; Vecchione C; Lembo G
Hypertension; 2007 Oct; 50(4):652-6. PubMed ID: 17664392
[TBL] [Abstract][Full Text] [Related]
13. The contribution of classical (beta1/2-) and atypical beta-adrenoceptors to the stimulation of human white adipocyte lipolysis and right atrial appendage contraction by novel beta3-adrenoceptor agonists of differing selectivities.
Sennitt MV; Kaumann AJ; Molenaar P; Beeley LJ; Young PW; Kelly J; Chapman H; Henson SM; Berge JM; Dean DK; Kotecha NR; Morgan HK; Rami HK; Ward RW; Thompson M; Wilson S; Smith SA; Cawthorne MA; Stock MJ; Arch JR
J Pharmacol Exp Ther; 1998 Jun; 285(3):1084-95. PubMed ID: 9618411
[TBL] [Abstract][Full Text] [Related]
14. The β-blocker Nebivolol Is a GRK/β-arrestin biased agonist.
Erickson CE; Gul R; Blessing CP; Nguyen J; Liu T; Pulakat L; Bastepe M; Jackson EK; Andresen BT
PLoS One; 2013; 8(8):e71980. PubMed ID: 23977191
[TBL] [Abstract][Full Text] [Related]
15. Requirement of vimentin filament assembly for beta3-adrenergic receptor activation of ERK MAP kinase and lipolysis.
Kumar N; Robidoux J; Daniel KW; Guzman G; Floering LM; Collins S
J Biol Chem; 2007 Mar; 282(12):9244-50. PubMed ID: 17251187
[TBL] [Abstract][Full Text] [Related]
16. Differentiation of bone marrow-derived cells toward thermogenic adipocytes in white adipose tissue induced by the β3 adrenergic stimulation.
Yoneshiro T; Shin W; Machida K; Fukano K; Tsubota A; Chen Y; Yasui H; Inanami O; Okamatsu-Ogura Y; Kimura K
FASEB J; 2019 Apr; 33(4):5196-5207. PubMed ID: 30624970
[TBL] [Abstract][Full Text] [Related]
17. Role of beta1- and beta3-adrenoceptors in the regulation of lipolysis and thermogenesis in rat brown adipocytes.
Atgié C; D'Allaire F; Bukowiecki LJ
Am J Physiol; 1997 Oct; 273(4):C1136-42. PubMed ID: 9357756
[TBL] [Abstract][Full Text] [Related]
18. Beta 3-adrenergic receptor-mediated lipolysis and oxygen consumption in brown adipocytes from cynomolgus monkeys.
Meyers DS; Skwish S; Dickinson KE; Kienzle B; Arbeeny CM
J Clin Endocrinol Metab; 1997 Feb; 82(2):395-401. PubMed ID: 9024225
[TBL] [Abstract][Full Text] [Related]
19. Impact of UCP1 and β3AR gene polymorphisms on age-related changes in brown adipose tissue and adiposity in humans.
Yoneshiro T; Ogawa T; Okamoto N; Matsushita M; Aita S; Kameya T; Kawai Y; Iwanaga T; Saito M
Int J Obes (Lond); 2013 Jul; 37(7):993-8. PubMed ID: 23032405
[TBL] [Abstract][Full Text] [Related]
20. Role of uncoupling protein 1 in the anti-obesity effect of beta3-adrenergic agonist in the dog.
Omachi A; Matsushita Y; Kimura K; Saito M
Res Vet Sci; 2008 Oct; 85(2):214-9. PubMed ID: 18406437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
